Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
L-arginine in MELAS Syndrome
NCT01603446Phase 2Completed
- Sponsor
- SickKids
- Start
- May 2012
- Primary completion
- May 2013
- Modality
- Peptides, Recombinant Proteins and Enzymes, Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of arginine in mitochondrial encephalomyopathy lactic acidosis and stroke-like episodes (MELAS), sponsored by SickKids. Started May 2012; status: completed.
02
Drugs
arginine
03
Conditions
mitochondrial encephalomyopathy lactic acidosis and stroke-like episodes (MELAS)
Beyond the preview
Go deeper on NCT01603446.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01603446.